Efficacy of Nanoparticle-incorporated Bonding Agent on Post-restorative Sensitivity
Clinical Efficacy of a Novel Titania Nanoparticle-Reinforced Bonding Agent in Reducing Post-Restorative Sensitivity: A Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Type of study: Randomized Clinical trial To compare post-restorative sensitivity between titania nanoparticle reinforced bonding agent and bonding agent without nanoparticles in posterior composite restorations. Participants aged 18 years and above with Class-I and Class-II Carious lesions are allocated in two groups. Group A will undergo composite restoration with Nanoparticles incorporated in bonding agent. Group B will undergo restoration without nanoparticles in bonding agent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedFirst Submitted
Initial submission to the registry
February 16, 2023
CompletedFirst Posted
Study publicly available on registry
February 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2023
CompletedSeptember 13, 2023
September 1, 2023
6 months
February 16, 2023
September 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-restorative sensitivity in composite resin restoration
Evaluation of bonding agent with titania nanoparticles and without nanoparticles on post-restorative sensitivity using Visual analog scale with scoring from 0 to 10. Score 10 means worst outcomes
1 month
Study Arms (2)
Group A
EXPERIMENTALGroup A will receive composite resin restoration with Titania nanoparticle incorporated bonding agent
Group B
EXPERIMENTALGroup B will receive composite resin restoration without Titania nanoparticle incorporated bonding agent
Interventions
Each group will receive Composite resin restoration for Class-I and Class-II carious lesion. In group A, titania nanoparticle reinforced bonding agent will be used
Composite resin restoration without Titania nanoparticle incorporated bonding agent
Eligibility Criteria
You may qualify if:
- Participants with good general health
- Selected teeth should be vital and periodontally healthy
- Class-I and II with minimal cavity depth of 3mm, not exceeding 5mm
- Defective previous restorations in need of replacement (secondary caries/fractures)
- Selected teeth should be in occlusion with natural or prosthetic antagonist and adjacent teeth
You may not qualify if:
- Patients with Temporomandibular disorders
- Extremely poor oral hygiene status
- Teeth with very deep carious lesions
- Teeth with periapical or periodontal pathology
- Patients taking anti-inflammatory, analgesics or psychotropic drugs
- History of spontaneous pain
- Previously root canal treated teeth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dentistry, Pakistan Institute of Medical Sciences
Islamabad, Pakistan
Related Publications (2)
Aboelenein AZ, Riad MI, Haridy MF. Effect of a Self-Etch Adhesive Containing Nanobioglass on Postoperative Sensitivity of Posterior Composite Restorations - A Randomized Trial. Open Access Maced J Med Sci. 2019 Jul 25;7(14):2313-2320. doi: 10.3889/oamjms.2019.585. eCollection 2019 Jul 30.
PMID: 31592280BACKGROUNDMelo MA, Cheng L, Zhang K, Weir MD, Rodrigues LK, Xu HH. Novel dental adhesives containing nanoparticles of silver and amorphous calcium phosphate. Dent Mater. 2013 Feb;29(2):199-210. doi: 10.1016/j.dental.2012.10.005. Epub 2012 Nov 6.
PMID: 23138046BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nehal Amir, BDS
Pakistan Institute of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- This is a triple-blinded study in which the participant, care provider and outcome assessor will be masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2023
First Posted
February 27, 2023
Study Start
January 5, 2023
Primary Completion
June 20, 2023
Study Completion
June 20, 2023
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share